South Korea
· Delayed Price · Currency is KRW OPTUS Pharmaceutical Statistics
Total Valuation
KOSDAQ:131030 has a market cap or net worth of KRW 102.25 billion. The enterprise value is 61.92 billion.
| Market Cap | 102.25B |
| Enterprise Value | 61.92B |
Important Dates
The next estimated earnings date is Thursday, July 24, 2025.
| Earnings Date | Jul 24, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
KOSDAQ:131030 has 16.15 million shares outstanding. The number of shares has increased by 0.25% in one year.
| Current Share Class | 16.15M |
| Shares Outstanding | 16.15M |
| Shares Change (YoY) | +0.25% |
| Shares Change (QoQ) | -0.16% |
| Owned by Insiders (%) | 0.80% |
| Owned by Institutions (%) | 5.44% |
| Float | 9.52M |
Valuation Ratios
The trailing PE ratio is 10.64.
| PE Ratio | 10.64 |
| Forward PE | n/a |
| PS Ratio | 1.25 |
| PB Ratio | 0.70 |
| P/TBV Ratio | 0.79 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 21.07 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.48, with an EV/FCF ratio of -4.66.
| EV / Earnings | 6.82 |
| EV / Sales | 0.76 |
| EV / EBITDA | 5.48 |
| EV / EBIT | 8.61 |
| EV / FCF | -4.66 |
Financial Position
The company has a current ratio of 5.15, with a Debt / Equity ratio of 0.01.
| Current Ratio | 5.15 |
| Quick Ratio | 3.96 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.11 |
| Debt / FCF | -0.09 |
| Interest Coverage | 80.49 |
Financial Efficiency
Return on equity (ROE) is 6.47% and return on invested capital (ROIC) is 3.17%.
| Return on Equity (ROE) | 6.47% |
| Return on Assets (ROA) | 2.89% |
| Return on Invested Capital (ROIC) | 3.17% |
| Return on Capital Employed (ROCE) | 4.91% |
| Revenue Per Employee | 515.44M |
| Profits Per Employee | 57.11M |
| Employee Count | 159 |
| Asset Turnover | 0.53 |
| Inventory Turnover | 2.50 |
Taxes
In the past 12 months, KOSDAQ:131030 has paid 1.44 billion in taxes.
| Income Tax | 1.44B |
| Effective Tax Rate | 13.72% |
Stock Price Statistics
The stock price has increased by +4.98% in the last 52 weeks. The beta is 0.46, so KOSDAQ:131030's price volatility has been lower than the market average.
| Beta (5Y) | 0.46 |
| 52-Week Price Change | +4.98% |
| 50-Day Moving Average | 6,192.20 |
| 200-Day Moving Average | 6,348.38 |
| Relative Strength Index (RSI) | 56.84 |
| Average Volume (20 Days) | 51,348 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KOSDAQ:131030 had revenue of KRW 81.95 billion and earned 9.08 billion in profits. Earnings per share was 594.76.
| Revenue | 81.95B |
| Gross Profit | 45.39B |
| Operating Income | 7.19B |
| Pretax Income | 10.52B |
| Net Income | 9.08B |
| EBITDA | 11.31B |
| EBIT | 7.19B |
| Earnings Per Share (EPS) | 594.76 |
Balance Sheet
The company has 41.59 billion in cash and 1.26 billion in debt, giving a net cash position of 40.33 billion or 2,496.57 per share.
| Cash & Cash Equivalents | 41.59B |
| Total Debt | 1.26B |
| Net Cash | 40.33B |
| Net Cash Per Share | 2,496.57 |
| Equity (Book Value) | 145.08B |
| Book Value Per Share | 9,490.96 |
| Working Capital | 56.35B |
Cash Flow
In the last 12 months, operating cash flow was 4.85 billion and capital expenditures -18.13 billion, giving a free cash flow of -13.27 billion.
| Operating Cash Flow | 4.85B |
| Capital Expenditures | -18.13B |
| Free Cash Flow | -13.27B |
| FCF Per Share | -821.78 |
Margins
Gross margin is 55.38%, with operating and profit margins of 8.78% and 11.08%.
| Gross Margin | 55.38% |
| Operating Margin | 8.78% |
| Pretax Margin | 12.84% |
| Profit Margin | 11.08% |
| EBITDA Margin | 13.80% |
| EBIT Margin | 8.78% |
| FCF Margin | n/a |
Dividends & Yields
KOSDAQ:131030 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | 16.80% |
| Buyback Yield | -0.25% |
| Shareholder Yield | n/a |
| Earnings Yield | 8.88% |
| FCF Yield | -12.98% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
KOSDAQ:131030 has an Altman Z-Score of 6.21 and a Piotroski F-Score of 4.
| Altman Z-Score | 6.21 |
| Piotroski F-Score | 4 |